Skip to main content

Peer Review reports

From: Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the “KetHead” trial

Original Submission
8 Nov 2022 Submitted Original manuscript
1 Dec 2022 Reviewed Reviewer Report - Alexander Gough
13 Jan 2023 Reviewed Reviewer Report - Amgad Rabie
1 Feb 2023 Author responded Author comments - Yasmine Hoydonckx
Resubmission - Version 2
1 Feb 2023 Submitted Manuscript version 2
8 Feb 2023 Reviewed Reviewer Report - Alexander Gough
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
18 Feb 2023 Editorially accepted
1 Mar 2023 Article published 10.1186/s13063-023-07186-3

You can find further information about peer review here.

Back to article page